131 related articles for article (PubMed ID: 15180861)
1. Phenotypic and functional characterization of monocyte-derived dendritic cells in chronic lymphocytic leukaemia patients: influence of neoplastic CD19 cells in vivo and in vitro.
Orsini E; Pasquale A; Maggio R; Calabrese E; Mauro FR; Giammartini E; Guarini A; Foa R
Br J Haematol; 2004 Jun; 125(6):720-8. PubMed ID: 15180861
[TBL] [Abstract][Full Text] [Related]
2. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.
Allgeier T; Garhammer S; Nössner E; Wahl U; Kronenberger K; Dreyling M; Hallek M; Mocikat R
Cancer Lett; 2007 Jan; 245(1-2):275-83. PubMed ID: 16516377
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia.
Hus I; Roliński J; Tabarkiewicz J; Wojas K; Bojarska-Junak A; Greiner J; Giannopoulos K; Dmoszyńska A; Schmitt M
Leukemia; 2005 Sep; 19(9):1621-7. PubMed ID: 15990861
[TBL] [Abstract][Full Text] [Related]
5. Blood dendritic cells in patients with chronic lymphocytic leukaemia.
Mami NB; Mohty M; Aurran-Schleinitz T; Olive D; Gaugler B
Immunobiology; 2008; 213(6):493-8. PubMed ID: 18514751
[TBL] [Abstract][Full Text] [Related]
6. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FoxP3+ regulatory T cells toward an antileukemia response.
Hus I; Schmitt M; Tabarkiewicz J; Radej S; Wojas K; Bojarska-Junak A; Schmitt A; Giannopoulos K; Dmoszyńska A; Roliński J
Leukemia; 2008 May; 22(5):1007-17. PubMed ID: 18323802
[TBL] [Abstract][Full Text] [Related]
8. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response.
Orsini E; Guarini A; Chiaretti S; Mauro FR; Foa R
Cancer Res; 2003 Aug; 63(15):4497-506. PubMed ID: 12907623
[TBL] [Abstract][Full Text] [Related]
9. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
[TBL] [Abstract][Full Text] [Related]
10. Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production.
Adamson L; Palma M; Choudhury A; Eriksson I; Näsman-Glaser B; Hansson M; Hansson L; Kokhaei P; Osterborg A; Mellstedt H
Scand J Immunol; 2009 Jun; 69(6):529-36. PubMed ID: 19439014
[TBL] [Abstract][Full Text] [Related]
11. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
12. Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia.
Vuillier F; Maloum K; Thomas EK; Jouanne C; Dighiero G; Scott-Algara D
Br J Haematol; 2001 Dec; 115(4):831-44. PubMed ID: 11843817
[TBL] [Abstract][Full Text] [Related]
13. Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.
Le Garff-Tavernier M; Decocq J; de Romeuf C; Parizot C; Dutertre CA; Chapiro E; Davi F; Debré P; Prost JF; Teillaud JL; Merle-Beral H; Vieillard V
Leukemia; 2011 Jan; 25(1):101-9. PubMed ID: 20975664
[TBL] [Abstract][Full Text] [Related]
14. Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome.
Montillo M; Schinkoethe T; Elter T
Cancer Invest; 2005; 23(6):488-96. PubMed ID: 16203656
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL.
Kokhaei P; Rezvany MR; Virving L; Choudhury A; Rabbani H; Osterborg A; Mellstedt H
Leukemia; 2003 May; 17(5):894-9. PubMed ID: 12750703
[TBL] [Abstract][Full Text] [Related]
16. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
[TBL] [Abstract][Full Text] [Related]
17. Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors.
Kokhaei P; Adamson L; Palma M; Osterborg A; Pisa P; Choudhury A; Mellstedt H
Cytotherapy; 2006; 8(4):318-26. PubMed ID: 16923607
[TBL] [Abstract][Full Text] [Related]
18. Efficient elimination of chronic lymphocytic leukaemia B cells by autologous T cells with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
Löffler A; Gruen M; Wuchter C; Schriever F; Kufer P; Dreier T; Hanakam F; Baeuerle PA; Bommert K; Karawajew L; Dörken B; Bargou RC
Leukemia; 2003 May; 17(5):900-9. PubMed ID: 12750704
[TBL] [Abstract][Full Text] [Related]
19. Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy.
Royer PJ; Bougras G; Ebstein F; Leveque L; Tanguy-Royer S; Simon T; Juge-Morineau N; Chevallier P; Harousseau JL; Gregoire M
Exp Hematol; 2008 Mar; 36(3):329-39. PubMed ID: 18207305
[TBL] [Abstract][Full Text] [Related]
20. Normal levels of peripheral CD19(+) CD5(+) CLL-like cells: toward a defined threshold for CLL follow-up -- a GEIL-GOELAMS study.
Durrieu F; Geneviève F; Arnoulet C; Brumpt C; Capiod JC; Degenne M; Feuillard J; Garand R; Kara-Terki A; Kulhein E; Maynadié M; Ochoa-Noguera ME; Plesa A; Roussel M; Eghbali H; Truchan-Graczyk M; de Carvalho Bittencourt M; Feugier P; Béné MC
Cytometry B Clin Cytom; 2011 Nov; 80(6):346-53. PubMed ID: 21976156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
